Abstract
Krev‐1 cDNA encodes a ras‐related protein and exhibits an activity of inducing flat revertants at certain frequencies (2‐5% of total transfectants) when introduced into a v‐K‐ras‐transformed mouse NIH3T3 cell line, DT. To explore the functional organization of Krev‐1 protein, we constructed a series of chimeric genes consisting of fragments of H‐ras and Krev‐1 cDNAs, and tested their biological activities in DT cells. The results indicated that the determinant for the transformation suppressor activity resides in the N‐terminal one‐third of the Krev‐1 encoded polypeptide within which a highly conserved, putative effector‐binding domain is present.
Keywords: Chimeric cDNA, H‐ras gene, Flat revertant
Full Text
The Full Text of this article is available as a PDF (252.3 KB).
REFERENCES
- 1. ) Noda , M. , Kitayama , H. , Matsuzaki , T. , Sugimoto , Y. , Okayama , H. , Bassin , R. H. and Ikawa , Y.Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes . Proc. Natl. Acad. Sci. USA , 86 , 162 – 166 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. ) Kitayama , H. , Sugimoto , Y. , Matsuzaki , T. , Ikawa , Y. and Noda , M.A ras‐related gene with transformation suppressor activity . Cell , 56 , 77 – 84 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Pizon , V. , Chardin , P. , Lerosey , I. , Olofsson , B. and Tavitian , A.Human cDNAs rap 1 and 2 homologous to the Drosophila gene Dras 3 encode proteins closely related to ras in the “effector” region . Oncogene , 3 , 201 – 204 ( 1988. ). [PubMed] [Google Scholar]
- 4. ) Kawata , M. , Matsui , Y. , Kondo , J. , Hishida , T. , Teranishi , Y. and Takai , Y.A novel small molecular weight GTP‐binding protein with the same putative effector domain as the ras proteins in bovine brain . J. Biol. Chem. , 263 , 18965 – 18971 ( 1988. ). [PubMed] [Google Scholar]
- 5. ) Willumsen , B. M. , Christensen , A. , Hubbert , N. L. , Papageorge , A. G. and Lowy , D. R.The p21 ras C‐terminus is required for transformation and membrane association . Nature , 310 , 583 – 586 ( 1984. ). [DOI] [PubMed] [Google Scholar]
- 6. ) McCormick , F. , Clark , B. F. C. , la Cour , T. F. M. , Kjeldgaard , M. , Norshov‐Lauritsen , L. and Nyborg , J.A model for the tertiary structure of p21, the product of the ras oncogene Science , 230 , 78 – 82 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Sigal , I. S. , Gibbs , J. B. , D'Alonzo , J. S. , Temeles , G. L. , Wolanski , B. S. , Socher , S. H. and Scolnick , E. M.Mutant ras‐proteins with altered nucleotide binding exert dominant biological effects . Proc. Natl. Acad. Sci. USA , 83 , 952 – 956 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. ) Willumsen , B. M. , Papageorge , A. G. , Kung , H‐F. , Bekesi , E. , Robins , T. , Johnsen , M. , Vass , W. C. and Lowy , D. R.Mutational analysis of a ras catalytic domain . Mol. Cell. Biol. , 6 , 2646 – 2654 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. ) Sigal , I. S. , Gibbs , J. B. , D'Alonzo , J. S. and Scolnick , E. M.Identification of effector residues and a neutralizing epitope of Ha‐ras‐encoded p21 . Proc. Natl. Acad. Sci. USA , 83 , 4725 – 4729 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. ) Fujiyama , A. and Tamanoi , F.Processing and fatty acid acylation of RAS1 and RAS2 proteins in Saccharomyces cerevisiae . Proc. Natl. Acad. Sci. USA , 83 , 1266 – 1270 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. ) Tong , L. , Milburn , M. V. , de Vos , A. M. and Kim , S‐H.Structure of ras protein . Science , 245 , 244 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 12. ) Pai , E. F. , Kabsch , W. , Krengel , U. , Holmes , K. C. , John , J. and Wittinghofer , A.Structure of the guanine‐nucleotide‐binding domain of the Ha‐ras oncogene product p21 in the triphosphate conformation . Nature , 341 , 209 – 214 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 13. ) Marshall , C.Human oncogenes . In “ RNA Tumor Viruses ,” vol. 2 , ed. Weiss R. , Teich N. , Varmus H. and Offin J. C. pp. 487 – 558 ( 1985. ). Cold Spring Harbor Laboratory; , New York . [Google Scholar]
- 14. ) Barbacid , M.ras Genes . Annu. Rev. Biochem. , 56 , 779 – 827 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 15. ) Schejter , E. D. and Shilo , B. Z.Characterization of functional domain of p21 ras by use of chimeric genes . EMBO J. , 4 , 407 – 412 ( 1985. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. ) Trahey , M. and McCormick , F.A cytoplasmic protein stimulates normal N‐ras p21 GTPase, but does not affect oncogenic mutants . Science , 238 , 542 – 545 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 17. ) Cales , C. , Hancock , J. F. , Marshall , C. J. and Hall , A.The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene product . Nature , 332 , 548 – 551 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 18. ) Vogel , U. S. , Dixon , R. A. , Schaber , M. D. , Diehl , R. E. , Marshall , M. S. , Scolnick , E. M. , Sigal , I. S. and Gibbs , J. B.Cloning of bovine GAP and its interaction with oncogenic ras p21 . Nature , 335 , 90 – 93 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 19. ) Adari , H. , Lowy , D. R. , Willumsen , B. M. , Der , C. J. and McCormick , F.Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain . Science , 240 , 518 – 521 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 20. ) McCormick , F.ras GTPase activating protein: signal transmitter and signal terminator . Cell , 56 , 5 – 8 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 21. ) Miller , A. D. and Rosman , G. J.Improved retroviral vectors for gene transfer and expression . Biotechniques , 7 , 980 – 990 ( 1989. ). [PMC free article] [PubMed] [Google Scholar]
- 22. ) Maniatis , T. , Fritsch , E. and Sambrook , J. “ Molecular Cloning: A Laboratory Manual ” ( 1982. ). Cold Spring Harbor Laboratory; , New York . [Google Scholar]
- 23. ) Kitayama , H. , Matsuzaki , T. , Ikawa , Y. and Noda , M.Genetic analysis of the Kirsten‐ras‐revertant 1 gene: potentiation of its tumor suppressor activity by specific point mutations . Proc. Natl. Acad. Sci. USA , in press . [DOI] [PMC free article] [PubMed]